cheap compounded tirzepatide (GLP-1/GIP) Lose up to 20% of your body weight with this simple Compounded vs regular tirzepatide: key

Description

Gastrointestinal effects are the most frequently reported side effects and include: Nausea (1224% of patients): Often most pronounced during treatment initiation and dose escalation, typically improving over time Diarrhea (1323% of patients): May be transient or persistent, requiring dietary modifications Vomiting (611% of patients): Can lead to dehydration if severe or prolonged Constipation (617% of patients): May require increased fiber intake and hydration Abdominal pain or discomfort (610% of patients): Usually mild to moderate in severity Decreased appetite : Therapeutic effect but may be excessive in some individuals These gastrointestinal symptoms generally diminish over several weeks as the body adjusts to the medication

Lancet Diabetes Endocrinol 2020;8:880-93.ArticlePubMed 115

La activacin del receptor GIP mejora la sensibilidad a la insulina y el metabolismo energtico

TLDR: This thread discusses the use of GLP-1 agonists for weight loss and whether some individuals naturally have higher levels of GLP-1, which might make them less prone to overeating and diabetes

The self-reporting part is an important limitation peoples reporting of their weight tends to be imprecise and well need more definitive proof from the Centers for Disease Control and Prevention to be sure, but its some of the earliest evidence that the US may finally be turning a corner on one of the biggest health crises of the modern age